Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/13/2012CA2505299C Novel biaromatic compunds which activate ppary type receptors, and use therof in cosmetic or pharmaceutical compositions
11/13/2012CA2502146C Solution formulations of sirolimus and its analogs for cad treatment
11/13/2012CA2495777C Synergistic uv absorber combination
11/13/2012CA2481142C Bisphosphonic acids for the treatment and prevention of osteoporosis
11/13/2012CA2473660C Ubiquinol-enriched fat-containing foods
11/13/2012CA2454306C Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use
11/13/2012CA2451643C Antisense modulation of superoxide dismutase 1, soluble expression
11/13/2012CA2428473C Method for producing pectin hydrolysis products
11/13/2012CA2417251C 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues
11/12/2012CA2766631A1 Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water-soluble extract from plant of solanum genus
11/12/2012CA2747509A1 Treatment of pulmonary and pleural fibrosis using hsp27 inhibitors
11/12/2012CA2740473A1 Canfosfamide monotherapy for treating multiple myeloma
11/10/2012CA2832202A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
11/08/2012WO2012151562A1 Combination pharmaceutical compositions and uses thereof
11/08/2012WO2012151561A1 Compounds for inhibiting cell proliferation in egfr-driven cancers
11/08/2012WO2012151559A2 Cytotoxic therapy by proton flux modulation
11/08/2012WO2012151554A1 Polyamines for treating biofilms
11/08/2012WO2012151541A1 Csf-1r inhibitors for treatment of brain tumors
11/08/2012WO2012151525A1 Novel compounds as modulators of protein kinases
11/08/2012WO2012151523A1 Csf-1r inhibitors for treatment of brain tumors
11/08/2012WO2012151517A1 Cochleate compositions and methods of making and using same
11/08/2012WO2012151512A2 Bromodomain inhibitors and uses thereof
11/08/2012WO2012151474A2 Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
11/08/2012WO2012151463A2 Methods for detecting enhanced risk of opioid-induced hypoxia in a patient
11/08/2012WO2012151452A1 Pyruvate kinase activators for use in therapy
11/08/2012WO2012151451A1 Pyruvate kinase activators for use in therapy
11/08/2012WO2012151450A1 Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
11/08/2012WO2012151448A1 Pyruvate kinase activators for use in therapy
11/08/2012WO2012151445A1 DERIVATIVES OF α-, β- AND γ-CYCLODEXTRIN AND THEIR USE AS ANTI-INFECTIVES
11/08/2012WO2012151440A1 Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia
11/08/2012WO2012151427A1 Transdermal compositions of ibuprofen and methods of use thereof
11/08/2012WO2012151420A1 2α-METHYL AND 2β-METHYL ANALOGS OF 19,26-DINOR-1α, 25-DIHYDROXYVITAMIN D3 AND THEIR USES
11/08/2012WO2012151413A1 Methods for treating prostate cancer
11/08/2012WO2012151361A1 Carbamoylpyridone derivatives
11/08/2012WO2012151355A1 Compounds for inflammation and immune-related uses
11/08/2012WO2012151343A1 Pentylenetetrazole derivatives
11/08/2012WO2012151326A1 Method of treating cancer and bone cancer pain
11/08/2012WO2012151319A1 Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain
11/08/2012WO2012151283A1 Drug substances, pharmeceutical compositions and methods for preparing the same
11/08/2012WO2012151252A2 Composition and method for treatment of diabetes
11/08/2012WO2012151165A1 Amorphous solid salts
11/08/2012WO2012151158A1 Isoxazolines as therapeutic agents
11/08/2012WO2012151153A1 Use of fk506 for the treatment of pulmonary arterial hypertension
11/08/2012WO2012151141A2 A facile preparation of 4-substituted quinazolines and related heterocycles
11/08/2012WO2012151140A1 Hydroxymethyl biaryl benzotriazole derivatives
11/08/2012WO2012151138A1 Cyclohexene benzotriazole derivatives
11/08/2012WO2012151137A1 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
11/08/2012WO2012151136A1 Aminomethyl biaryl benzotriazole derivatives
11/08/2012WO2012151114A1 Diazeniumdiolate cyclohexyl derivatives
11/08/2012WO2012151058A1 (20s)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin d3 analogs and their uses
11/08/2012WO2012151039A2 Compositions and methods for detecting mycobacterium
11/08/2012WO2012150952A1 Novel compounds and compositions for the inhibition of nampt
11/08/2012WO2012150903A1 Food product comprising rye
11/08/2012WO2012150892A1 Treatment of psoriasis
11/08/2012WO2012150866A1 Phosphoribosyltransferase inhibitors and uses thereof
11/08/2012WO2012150857A1 Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (arg)
11/08/2012WO2012150839A2 Method for microencapsulating phosphatidylserine
11/08/2012WO2012150829A2 Noble triazolopyridine derivative or pharmaceutically acceptable salts thereof, production method thereof, and pharmaceutical composition including same
11/08/2012WO2012150784A2 Novel indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient
11/08/2012WO2012150747A1 Method for manufacturing garlic oil and butter containing ajoene
11/08/2012WO2012150707A1 Low molecular weight compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using low molecular weight compound
11/08/2012WO2012150683A1 Method for utilizing extraction residue of yeast extract
11/08/2012WO2012150675A1 Panaxadiol-containing composition
11/08/2012WO2012150663A1 Improved sugar-coated liposome composition
11/08/2012WO2012150583A1 Eye drops for treatment of conjunctivochalasis
11/08/2012WO2012150582A1 Edible oil for seniors
11/08/2012WO2012150577A1 Compounds with antiparasitic activity and applications thereof
11/08/2012WO2012150561A1 Rifaximin dimethylformamide solvate
11/08/2012WO2012150550A1 Novel pesticidal amino pyranone compounds
11/08/2012WO2012150543A1 Macrocyclic lactones and use thereof
11/08/2012WO2012150538A1 Crystalline salts of asenapine
11/08/2012WO2012150520A1 Novel cephalosporins useful as antibacterial agents
11/08/2012WO2012150486A1 A composition for treating autoimmune disorders and methods thereof
11/08/2012WO2012150450A1 Oral compositions comprising creatine
11/08/2012WO2012150412A1 Novel combination of 4-(3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy)benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing same
11/08/2012WO2012150370A1 Synergic polyphenol combination
11/08/2012WO2012150369A1 Phosphodiesterase-7-inhibiting heterocyclic derivatives
11/08/2012WO2012150340A1 Compounds for use in the treatment of filariasis
11/08/2012WO2012150305A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO- DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES
11/08/2012WO2012150299A2 Treatment of hyperproliferative diseases of the urogenital tract
11/08/2012WO2012150269A1 Probiotic bacteria for the topical treatment of skin disorders
11/08/2012WO2012150255A1 Bis-(alpha-amino-diol-diester) containing polyesteramide for ophtamology
11/08/2012WO2012150245A1 Katp antagonists (glibenglamid) for use for promoting growth and/or treating hyperglycaemia of a premature infant
11/08/2012WO2012150234A1 Dihydroquinoline derivatives as bromodomain inhibitors
11/08/2012WO2012150231A1 Novel benzofurane-piperidine compounds
11/08/2012WO2012150220A1 Radiolabeled amino acids for diagnostic imaging
11/08/2012WO2012150202A1 Isoindolinone derivatives
11/08/2012WO2012150183A1 Crystalline sodium salt of an hiv integrase inhibitor
11/08/2012WO2012150146A1 Composition useful for the treatment of lipid metabolism disorders
11/08/2012WO2012150131A1 Improved suspension formulation of a corticosteroid for administration by inhalation
11/08/2012WO2012150130A1 A topical formulation comprising a corticosteroid as active ingredient
11/08/2012WO2012150042A1 Compounds and methods for the identification of histone demethylase interacting molecules and for the purification of histone demethylase proteins
11/08/2012WO2012149906A1 Modified nucleic acid structure having anti-hiv-1 fusion activity
11/08/2012WO2012149667A1 Cardenolide compounds and antitumor use thereof
11/08/2012WO2012149646A1 Mirna inhibitors and their uses
11/08/2012WO2012149608A1 Prenylated hydroxystilbenes
11/08/2012WO2012149602A1 Multiple myeloma treatment
11/08/2012WO2012125996A9 Denture adhesive remover for intraoral and extraoral use
11/08/2012WO2012125832A3 Antimicrobial agents
11/08/2012WO2012125828A3 Methods of treating breast cancer with anthracycline therapy
1 ... 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 ... 7860